Journal article

Reply: 'More viral mutants, less HBsAg clearance? One size may not fit all'

Alex Thompson, Stephen Locarnini, Peter Revill

Gut | BMJ PUBLISHING GROUP | Published : 2017

DOI: 10.1136/gutjnl-2016-313287

University of Melbourne Researchers

Stephen Locarnini Author Microbiology and Immunology

Peter Revill Author Microbiology and Immunology

Alex Thompson Author Medicine - St Vincent's Hospital

Grants

Funding Acknowledgements

Gilead Sciences.

Citation metrics

Keywords

Chronic Hepatitis-B

Antiviral Therapy

Life Sciences & Biomedicine

Gastroenterology & Hepatology

Tenofovir Disoproxil Fumarate

Science & Technology

Hepatitis B E Antigens

Hepatitis B Virus

Hepatitis B, Chronic

Antiviral Agents

Surface-Antigen Loss

Hepatitis B Surface Antigens